Powered by

Wolf Popper LLP Announces Investigation on Behalf of Investors in Stemline Therapeutics, Inc.

Feb 27, 2017 - PR Newswire

Wolf Popper LLP is investigating potential securities fraud claims on behalf of investors in Stemline Therapeutics, Inc. securities (NASDAQ: STML) during the period January 6, 2017 through February 1, 2017. Such investors are advised to contact Fei-Lu Qian at 877.370.7703 orfqian@wolfpopper.com

Several class action lawsuits have already been filed.  If you wish to serve as lead plaintiff, you must move the Court no later than April 4, 2017.  A lead plaintiff is a representative party act...